LINCOLN NATIONAL CORP - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 39 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
LINCOLN NATIONAL CORP ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2023$2,131
-46.7%
11,215
+8.7%
0.00%
Q2 2022$4,000
-69.2%
10,3150.0%0.00%
Q1 2022$13,0000.0%10,3150.0%0.00%
Q4 2021$13,000
-40.9%
10,315
+3.2%
0.00%
-100.0%
Q4 2019$22,00010,0000.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q1 2022
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$44,0000.03%
Brown Advisory Securities, LLC 28,000$35,0000.02%
Murchinson Ltd. 76,404$96,0000.02%
WEBSTER BANK, N. A. 80,000$101,0000.01%
Patriot Financial Group Insurance Agency, LLC 34,650$44,0000.01%
WMS Partners, LLC 42,000$53,0000.01%
Willow Creek Wealth Management Inc. 18,724$24,0000.01%
Cubic Asset Management, LLC 14,000$18,0000.00%
CVI Holdings, LLC 45,993$58,0000.00%
One Day In July LLC 10,000$13,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders